{"id":"8fa9215c-8f41-4600-81fd-4c145caefdd4","modelId":"5a1c4db9-069d-4fdb-8ace-9917a3255ed1","versionId":null,"locationId":"94b72ada-cafc-4321-a524-cb8e576bb849","operatorId":"e6c82ae9-e819-484a-8b07-cabfbe90e3cc","ownerId":null,"slug":"cyberdyne-hal-japan","status":"operational","firstSeen":"2008-01-01T12:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":null,"shiftStructure":null,"hoursPerDay":null,"siteType":null,"operatorConfirmed":false,"humanSupervisionOnsite":null,"locationPrecisionTier":null,"deploymentScale":null,"siteEnvironment":null,"operatorType":"maker_operated","sourceQualityTier":null,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.cyberdyne.jp/english/products/LowerLimb_medical.html","title":"MEDICAL HAL (LOWER LIMB TYPE)","sourceName":"Cyberdyne"},{"url":"https://www.cyberdyne.jp/english/company/PressReleases_detail.html?id=14303","title":"Tochigi Robocare Opens ~18th Robocare Center in Japan","sourceName":"Cyberdyne"}],"notes":"Cyberdyne HAL has been in clinical use in Japan since 2008. The medical HAL Lower Limb Type is approved and covered by public health insurance for 10 diseases. 120 units under domestic rental contracts as of March 2026. 18 Robocare Centers offer the non-medical Neuro HALFIT program. A smaller pediatric model (100-150 cm) was approved in January 2025. New consolidated model launched May 2026.","keyFacts":[{"label":"Medical HAL Lower Limb units (domestic)","value":"120 units under rental contracts as of March 2026"},{"label":"Robocare Centers","value":"18 centers across Japan offering Neuro HALFIT (non-medical) plus home-based rental"},{"label":"Insurance coverage","value":"Public health insurance covers 10 neurological/muscular diseases"},{"label":"New model launch","value":"Consolidated medical HAL Lower Limb launched May 2026 (2 waist-width configs, 150-190 cm)"}],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-06-07T13:21:36.698Z","updatedAt":"2026-07-22T03:48:48.787Z","model":{"id":"5a1c4db9-069d-4fdb-8ace-9917a3255ed1","companyId":"e6c82ae9-e819-484a-8b07-cabfbe90e3cc","modelName":"Cyberdyne HAL","slug":"cyberdyne-hal","description":"Powered (motor-driven) exoskeleton whose distinguishing feature is bioelectric-signal control: skin-surface sensors detect the faint nerve/muscle signals of intended movement and drive the actuators in sync. Medical lower-limb version FDA cleared 2017; clinical use in Japan since 2008.","formFactor":"exoskeleton","industryVertical":null,"environment":null,"maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"use":"medical rehab","control":"bioelectric-signal (skin-surface intention sensing)","powered":"yes (motor-driven)","height_cm":123,"weight_kg":14,"regulatory":"FDA cleared 2017 (medical lower-limb)","body_region":"lower-limb (also full-body variants)","availability":"commercial"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://en.wikipedia.org/wiki/Cyberdyne_Inc.","title":"Cyberdyne HAL","sourceName":"Wikipedia"},{"url":"https://www.borntoengineer.com/cyberdyne-japanese-exoskeleton-gets-fda-approval","title":"Cyberdyne HAL FDA approval","sourceName":"Born to Engineer"},{"url":"https://www.cyberdyne.jp/en/products/hal-lowerlimb-wellbeing","title":"Well-Being HAL","sourceName":"Cyberdyne (official)"}],"aliases":["HAL","Hybrid Assistive Limb"],"collisionRisk":"low","reviewNote":"reverified 2026-06-09 (Kimi-incident remediation): cited primary source resolves and matches manufacturer/reputable domain; relevance adjudicated.","manufacturerTermForTeleop":null,"keyFacts":[{"label":"Robot","value":"HAL (Hybrid Assistive Limb) is a powered exoskeleton that reads bioelectric signals from the user's skin to drive its motors."},{"label":"Focus","value":"Cybernics company developing assistive exoskeleton technology."},{"label":"Product","value":"HAL (Hybrid Assistive Limb) exoskeleton"},{"label":"Fund","value":"0M with Pegasus Tech Ventures for physical AI"},{"label":"FDA approval","value":"October 2020 (HAL for medical use)"},{"label":"Japan medical device approval","value":"January 2025 (small-size HAL)"}],"createdAt":"2026-06-06T01:25:41.568Z","updatedAt":"2026-07-15T13:22:06.176Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"e6c82ae9-e819-484a-8b07-cabfbe90e3cc","name":"Cyberdyne","slug":"cyberdyne","description":"Cyberdyne Inc. is a Japanese robotics company founded in 2004 by Dr. Yoshiyuki Sankai, professor at the University of Tsukuba, to commercialize the Hybrid Assistive Limb (HAL), a brain-controlled exoskeleton for medical and industrial use. HAL received FDA approval in 2020 and medical device approval in Japan for its small-size model in 2025. The company's exoskeletons are deployed in hospitals and healthcare facilities across Japan, Europe, and the United States for treating patients with spinal cord injuries and neurological disorders.","status":"public (TSE: 7779)","founded":2004,"hq":"Tsukuba, Japan","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://en.wikipedia.org/wiki/Cyberdyne_Inc.","title":"Cyberdyne","sourceName":"Wikipedia"},{"url":"https://www.borntoengineer.com/cyberdyne-japanese-exoskeleton-gets-fda-approval","title":"Cyberdyne HAL FDA approval","sourceName":"Born to Engineer"}],"keyFacts":[{"label":"Robot","value":"HAL (Hybrid Assistive Limb) is a powered exoskeleton that reads bioelectric signals from the user's skin to drive its motors."},{"label":"Focus","value":"Cybernics company developing assistive exoskeleton technology."},{"label":"CEO","value":"Yoshiyuki Sankai (Founder, PhD)"},{"label":"Product","value":"HAL (Hybrid Assistive Limb) exoskeleton"},{"label":"Stock","value":"Tokyo Stock Exchange (TYO: 7749)"},{"label":"Fund","value":"0M with Pegasus Tech Ventures for physical AI"},{"label":"FDA approval","value":"October 2020 (HAL for medical use)"},{"label":"Japan medical device approval","value":"January 2025 (small-size HAL)"}],"aliases":["Cyberdyne Inc"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"7749","stockExchange":"TYO","secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-06T01:25:38.275Z","updatedAt":"2026-07-22T16:32:25.276Z"}},"version":null,"location":{"id":"94b72ada-cafc-4321-a524-cb8e576bb849","name":"Japan","slug":"japan","kind":"country","parentLocationId":null,"region":null,"lat":36.2048,"lng":138.2529,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-05-31T14:45:15.579Z","updatedAt":"2026-07-02T22:50:37.655Z"},"operator":{"id":"e6c82ae9-e819-484a-8b07-cabfbe90e3cc","name":"Cyberdyne","slug":"cyberdyne","description":"Cyberdyne Inc. is a Japanese robotics company founded in 2004 by Dr. Yoshiyuki Sankai, professor at the University of Tsukuba, to commercialize the Hybrid Assistive Limb (HAL), a brain-controlled exoskeleton for medical and industrial use. HAL received FDA approval in 2020 and medical device approval in Japan for its small-size model in 2025. The company's exoskeletons are deployed in hospitals and healthcare facilities across Japan, Europe, and the United States for treating patients with spinal cord injuries and neurological disorders.","status":"public (TSE: 7779)","founded":2004,"hq":"Tsukuba, Japan","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://en.wikipedia.org/wiki/Cyberdyne_Inc.","title":"Cyberdyne","sourceName":"Wikipedia"},{"url":"https://www.borntoengineer.com/cyberdyne-japanese-exoskeleton-gets-fda-approval","title":"Cyberdyne HAL FDA approval","sourceName":"Born to Engineer"}],"keyFacts":[{"label":"Robot","value":"HAL (Hybrid Assistive Limb) is a powered exoskeleton that reads bioelectric signals from the user's skin to drive its motors."},{"label":"Focus","value":"Cybernics company developing assistive exoskeleton technology."},{"label":"CEO","value":"Yoshiyuki Sankai (Founder, PhD)"},{"label":"Product","value":"HAL (Hybrid Assistive Limb) exoskeleton"},{"label":"Stock","value":"Tokyo Stock Exchange (TYO: 7749)"},{"label":"Fund","value":"0M with Pegasus Tech Ventures for physical AI"},{"label":"FDA approval","value":"October 2020 (HAL for medical use)"},{"label":"Japan medical device approval","value":"January 2025 (small-size HAL)"}],"aliases":["Cyberdyne Inc"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"7749","stockExchange":"TYO","secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-06T01:25:38.275Z","updatedAt":"2026-07-22T16:32:25.276Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/cyberdyne-hal-japan","url":"https://registry.deploy.report/deployments/cyberdyne-hal-japan","name":"Cyberdyne HAL at Japan","identifier":"8fa9215c-8f41-4600-81fd-4c145caefdd4","startDate":"2008-01-01T12:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/japan","name":"Japan"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/cyberdyne","name":"Cyberdyne"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/cyberdyne-hal","name":"Cyberdyne HAL"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"exoskeleton","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":2,"primary_source_types":[]}}}